CD9 and cancer: However, this experiment strategy of targeting human CD9 and CD63 is only applicable in a xenograft nude mouse model for selectively eliminating human cancer sEVs from the blood, since CD9 and CD63 are expressed in sEVs released from both noncancerous and cancerous cells in humans.